Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
基本信息
- 批准号:6478574
- 负责人:
- 金额:$ 35.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-01 至 2005-04-30
- 项目状态:已结题
- 来源:
- 关键词:BCL2 gene /protein Bax gene /protein SDS polyacrylamide gel electrophoresis age difference aging apoptosis coronary occlusion /thrombosis cytochrome c densitometry electron microscopy electrospray ionization mass spectrometry free radicals high performance liquid chromatography laboratory rat matrix assisted laser desorption ionization monoclonal antibody proteasome reperfusion western blottings
项目摘要
DESCRIPTION: (provided by applicant) Complications arising from reduction of
blood supply to the heart are a leading cause of death and debilitation
worldwide. Depending on the duration and severity of the ischemic event,
irreparable alterations in cellular homeostasis lead to necrotic cell death.
However, reperfusion of viable cardiac tissue can result in cell death by
processes unrelated to necrosis. This has been attributed, in part, to
increases in the production of oxygen radicals and the induction of programmed
cell death, termed apoptosis. The proteasome, a major intracellular proteolytic
system, appears to play a critical role in the prevention of apoptosis by
degrading certain pro-apoptotic factors. Nevertheless, the proteasome is itself
modified by free radical processes and exhibits dramatic declines in activity
as a result of coronary occlusion/reperfusion. Furthermore, proteasome
expression and specific activity decrease as a function of age. The objectives
of the proposed research are to establish a mechanistic link between age and
free radical induced loss in proteasome function and stimulation of the
apoptotic process during coronary occlusion/reperfusion. Utilizing a
physiologically relevant in vivo rat model of coronary occlusion and
reperfusion this study seeks to: 1) Identify alterations in proteasome
activity; 2) Defme free radical processes which result in loss in proteasome
activity; 3) Characterize the progression of apoptosis; and 4) Establish
mechanisms by which proteasome inactivation enhances apoptosis. In each aim,
the effects of duration of occlusion and reperfusion and age of the animal will
be assessed. Thus, these studies will establish biochemical mechanisms by which
proteasome function is altered and when, in the sequence of coronary occlusion
and reperfusion, critical oxidative events occur. Furthermore, the role of
proteasome inactivation in the induction of apoptosis will be established.
Finally, the contribution of age-dependent declines in proteasome activity to
the progression and extent of coronary occlusion/reperfusion induced apoptosis
will be elucidated. Results of the proposed study will therefore define
molecular events which are likely to impact the long term progression of heart
disease and indicate efficient strategies for favorably influencing the
outcome.
描述:(由申请人提供)减少
心脏供血不足是导致死亡和衰弱的主要原因
国际吧根据缺血事件的持续时间和严重程度,
细胞内稳态不可修复的改变导致坏死性细胞死亡。
然而,存活心脏组织的再灌注可通过以下方式导致细胞死亡:
与坏死无关的过程。部分原因是,
增加氧自由基的产生和诱导编程
细胞死亡,称为凋亡。蛋白酶体是一种主要的细胞内蛋白水解酶
系统,似乎发挥了关键作用,在预防细胞凋亡,
降解某些促凋亡因子。然而,蛋白酶体本身
被自由基过程修饰,并表现出活性急剧下降,
冠状动脉闭塞/再灌注的结果。此外,蛋白酶
表达和比活性作为年龄的函数而降低。目标
研究的目的是建立年龄与
自由基诱导的蛋白酶体功能丧失和刺激
冠状动脉闭塞/再灌注期间的细胞凋亡过程。利用
冠状动脉闭塞的生理学相关的体内大鼠模型,
本研究旨在:1)确定蛋白酶体的改变
活性; 2)定义导致蛋白酶体损失的自由基过程
活性; 3)表征细胞凋亡的进展;和4)建立
蛋白酶体失活增强细胞凋亡的机制。在每一个目标中,
闭塞和再灌注的持续时间以及动物的年龄的影响将
进行评估。因此,这些研究将建立生化机制,
蛋白酶体功能改变,并且当在冠状动脉闭塞的顺序中,
和再灌注时,发生关键的氧化事件。此外,
蛋白酶体失活在细胞凋亡诱导中的作用。
最后,蛋白酶体活性的年龄依赖性下降,
冠状动脉闭塞/再灌注诱导细胞凋亡的进展和程度
将被阐明。因此,拟议研究的结果将确定
可能影响心脏病长期进展的分子事件
疾病,并指出有效的策略,有利地影响
结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LUKE I. SZWEDA其他文献
LUKE I. SZWEDA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LUKE I. SZWEDA', 18)}}的其他基金
Diversity Supplement-Oxidative DNA Damage Regulates Cardiomyocyte Proliferation
多样性补充-氧化DNA损伤调节心肌细胞增殖
- 批准号:
9898738 - 财政年份:2018
- 资助金额:
$ 35.6万 - 项目类别:
Oxidative DNA Damage Regulates Cardiomyocyte Proliferation
DNA 氧化损伤调节心肌细胞增殖
- 批准号:
9921473 - 财政年份:2018
- 资助金额:
$ 35.6万 - 项目类别:
Oxidative DNA Damage Regulates Cardiomyocyte Proliferation
DNA 氧化损伤调节心肌细胞增殖
- 批准号:
9752677 - 财政年份:2018
- 资助金额:
$ 35.6万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
6625766 - 财政年份:2002
- 资助金额:
$ 35.6万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
7020621 - 财政年份:2002
- 资助金额:
$ 35.6万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
6743130 - 财政年份:2002
- 资助金额:
$ 35.6万 - 项目类别:
Modulation of Mitochondrial Function by Pro-Oxidants
促氧化剂对线粒体功能的调节
- 批准号:
7897640 - 财政年份:1999
- 资助金额:
$ 35.6万 - 项目类别:
AGING, LIPID PEROXIDATION, AND CARDIAC REPERFUSION
衰老、脂质过氧化和心脏再灌注
- 批准号:
2743533 - 财政年份:1999
- 资助金额:
$ 35.6万 - 项目类别:
AGING, LIPID PEROXIDATION, AND CARDIAC REPERFUSION
衰老、脂质过氧化和心脏再灌注
- 批准号:
6626440 - 财政年份:1999
- 资助金额:
$ 35.6万 - 项目类别:
AGING, LIPID PEROXIDATION, AND CARDIAC REPERFUSION
衰老、脂质过氧化和心脏再灌注
- 批准号:
6488849 - 财政年份:1999
- 资助金额:
$ 35.6万 - 项目类别:














{{item.name}}会员




